Perceptive Advisors - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q3 2023$220,229,445
-31.3%
10,088,3850.0%7.35%
-20.9%
Q2 2023$320,709,759
+101.9%
10,088,385
+54.9%
9.28%
+97.9%
Q1 2023$158,851,021
-22.7%
6,511,7270.0%4.69%
-18.7%
Q4 2022$205,379,869
+11.6%
6,511,7270.0%5.77%
+8.0%
Q3 2022$184,021,000
+36.8%
6,511,727
+28.0%
5.34%
+26.8%
Q2 2022$134,493,000
-24.5%
5,086,7270.0%4.21%
+18.1%
Q1 2022$178,086,000
-46.0%
5,086,727
-50.0%
3.57%
+40.2%
Q4 2021$329,822,000
+119.8%
10,173,454
+100.0%
2.54%
+16.7%
Q3 2021$150,058,000
-36.9%
5,086,727
-45.2%
2.18%
+41.1%
Q2 2021$237,912,000
+273.2%
9,286,190
+100.0%
1.54%
+91.7%
Q1 2021$63,749,000
-15.4%
4,643,095
+2.2%
0.81%
-0.4%
Q4 2020$75,340,0004,544,0620.81%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2021
NameSharesValueWeighting ↓
BAIN CAPITAL INVESTORS LLC 60,199,729$1,314,160,08442.08%
Perceptive Advisors 10,088,385$220,229,4457.35%
Finepoint Capital LP 563,345$12,297,8216.12%
Affinity Asset Advisors, LLC 685,061$14,954,8824.21%
Paradigm Biocapital Advisors LP 2,532,972$55,294,7793.75%
Logos Global Management LP 700,000$15,281,0002.04%
Artal Group S.A. 1,638,858$35,7761.53%
Rock Springs Capital Management LP 2,529,116$55,210,6021.48%
GREAT POINT PARTNERS LLC 215,000$4,693,4500.86%
Frazier Life Sciences Management, L.P. 393,000$8,579,1900.57%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders